Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Phase III Long-Term Extension Study With Dexpramipexole

ClinicalTrials.gov ID: NCT06388889

Public ClinicalTrials.gov record NCT06388889. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 12:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Long-Term Phase III Extension Study to Assess the Long-Term Safety and Tolerability of Dexpramipexole in Participants With Severe Eosinophilic Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical trial\] is to evaluate the long term safety of dexpramipexole treatment in participants with severe asthma, aged ≥18 years, on Global Initiative for Asthma (GINA) 2021 \[GINA, 2021\] Step 4 or 5 therapy and who completed either of the Phase III studies EXHALE-2 or EXHALE-3.

Study identification

NCT ID
NCT06388889
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Areteia Therapeutics
Industry
Enrollment
509 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 11, 2024
Primary completion
Dec 7, 2025
Completion
Dec 7, 2025
Last update posted
Dec 14, 2025

2024 – 2025

United States locations

U.S. sites
23
U.S. states
9
U.S. cities
16
Facility City State ZIP Site status
Research Site 20001-374 Bakersfield California 93301
Research Site 20001-376 Northridge California 91324
Research Site 20001-029 Coral Gables Florida 33134
Research Site 20001-014 Greenacres City Florida 33467
Research Site 30001-291 Jacksonville Florida 32216
Research Site 20001-066 Miami Florida 33126
Research Site 20001-001 Miami Florida 33135
Research Site 20001-311 Miami Florida 33144
Research Site 20001-026 Miami Florida 33155
Research Site 30001-082 Miami Florida 33179
Research Site 20001-024 Miami Florida 33184
Research Site 20054-024 Miami Florida 33184
Research Site 30001-429 Plantation Florida 33137
Research Site 30001-429 Plantation Florida 33317
Research Site 20001-004 Tampa Florida 33607
Research Site 20001-036 Elwood Indiana 46036
Research Site 20001-044 Evansville Indiana 47715
Research Site 20001-006 Flint Michigan 48504
Research Site 20001-046 St Louis Missouri 63110
Research Site 20001-355 Toms River New Jersey 08755
Research Site 20001-047 Hawthorne New York 10532
Research Site 20001-063 Toledo Ohio 43617
Research Site 30001-297 Pearland Texas 77584

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 80 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06388889, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 14, 2025 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06388889 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →